Caseware UK (AP4) 2024.0.164 2024.0.164 2025-07-312025-07-312024-08-01falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.falseNo description of principal activity11truetrue 06642165 2024-08-01 2025-07-31 06642165 2023-08-01 2024-07-31 06642165 2025-07-31 06642165 2024-07-31 06642165 c:Director1 2024-08-01 2025-07-31 06642165 d:CurrentFinancialInstruments 2025-07-31 06642165 d:CurrentFinancialInstruments 2024-07-31 06642165 d:CurrentFinancialInstruments d:WithinOneYear 2025-07-31 06642165 d:CurrentFinancialInstruments d:WithinOneYear 2024-07-31 06642165 d:ShareCapital 2025-07-31 06642165 d:ShareCapital 2024-07-31 06642165 d:RetainedEarningsAccumulatedLosses 2025-07-31 06642165 d:RetainedEarningsAccumulatedLosses 2024-07-31 06642165 c:FRS102 2024-08-01 2025-07-31 06642165 c:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 06642165 c:FullAccounts 2024-08-01 2025-07-31 06642165 c:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 06642165 2 2024-08-01 2025-07-31 06642165 e:PoundSterling 2024-08-01 2025-07-31 iso4217:GBP xbrli:pure

Registered number: 06642165









GMS CLINICS AND HOSPITALS LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 JULY 2025

 
GMS CLINICS AND HOSPITALS LIMITED
 

CONTENTS



Page
Balance sheet
 
1 - 2
Notes to the financial statements
 
3 - 6


 
GMS CLINICS AND HOSPITALS LIMITED
REGISTERED NUMBER: 06642165

BALANCE SHEET
AS AT 31 JULY 2025

2025
2024
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
47,591
22,398

Cash at bank and in hand
 5 
22,247
64,716

  
69,838
87,114

Creditors: amounts falling due within one year
 6 
(36,265)
(52,849)

Net current assets
  
 
 
33,573
 
 
34,265

Total assets less current liabilities
  
33,573
34,265

  

Net assets
  
33,573
34,265


Capital and reserves
  

Called up share capital 
  
2
2

Profit and loss account
  
33,571
34,263

  
33,573
34,265


Page 1

 
GMS CLINICS AND HOSPITALS LIMITED
REGISTERED NUMBER: 06642165
    
BALANCE SHEET (CONTINUED)
AS AT 31 JULY 2025

The Directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The Directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
S Yoffe
Director

Date: 12 December 2025

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
GMS CLINICS AND HOSPITALS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

1.


General information

GMS Clinics and Hospitals Limited is a private company, limited by shares, incorporated England and Wales and its registered office is 46 Dorset Street, Suite 1, London, England, W1U 7NB 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

 
GMS CLINICS AND HOSPITALS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

2.Accounting policies (continued)

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.6

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 4

 
GMS CLINICS AND HOSPITALS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

2.Accounting policies (continued)

 
2.10

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

 
2.11

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2024 - 1).


4.


Debtors

2025
2024
£
£


Other debtors
47,591
22,398



5.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
22,247
64,716


Page 5

 
GMS CLINICS AND HOSPITALS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

6.


Creditors: Amounts falling due within one year

2025
2024
£
£

Corporation tax
-
5,920

Accruals and deferred income
36,265
46,929

36,265
52,849



7.


Controlling party

The ultimate parent undertaking and controlling party is SM-PIK B.V., a company incorporated and domiciled in the Netherlands.

 
Page 6